1. Home
  2. SOTK vs UNCY Comparison

SOTK vs UNCY Comparison

Compare SOTK & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sono-Tek Corporation

SOTK

Sono-Tek Corporation

HOLD

Current Price

$5.32

Market Cap

72.1M

Sector

Technology

ML Signal

HOLD

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

BUY

Current Price

$3.83

Market Cap

150.1M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
SOTK
UNCY
Founded
1975
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.1M
150.1M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
SOTK
UNCY
Price
$5.32
$3.83
Analyst Decision
Buy
Strong Buy
Analyst Count
2
10
Target Price
$8.50
★ $28.40
AVG Volume (30 Days)
134.4K
★ 859.1K
Earning Date
10-14-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 37.50
N/A
EPS
★ 0.07
N/A
Revenue
★ $20,909,315.00
$675,000.00
Revenue This Year
$2.59
N/A
Revenue Next Year
$23.41
$10,812.60
P/E Ratio
$77.71
★ N/A
Revenue Growth
★ 1.97
N/A
52 Week Low
$3.40
$3.35
52 Week High
$7.48
$8.74

Technical Indicators

Market Signals
Indicator
SOTK
UNCY
Relative Strength Index (RSI) 43.09 27.32
Support Level $4.07 N/A
Resistance Level $5.81 $5.86
Average True Range (ATR) 0.70 0.19
MACD -0.10 -0.06
Stochastic Oscillator 8.52 13.83

Price Performance

Historical Comparison
SOTK
UNCY

About SOTK Sono-Tek Corporation

Sono-Tek Corp designs and manufactures ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial, and emerging research & development/other markets. The company designs and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with applications engineering knowledge, to assist its customers in achieving their desired coating solutions.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.

Share on Social Networks: